Allergy Unit, Meyer Children’s Hospital IRCCS, 50139 Florence, Italy
Stefania Arasi
Translational Research in Pediatric Specialties Area, Division of Allergy, Bambino Gesù Children’s Hospital [IRCCS], 00165 Rome, Italy
Simona Barni
Allergy Unit, Meyer Children’s Hospital IRCCS, 50139 Florence, Italy
Mattia Giovannini
Allergy Unit, Meyer Children’s Hospital IRCCS, 50139 Florence, Italy
Lucia Caminiti
Department of Human Pathology in Adult and Development Age “Gaetano Barresi”, Allergy Unit, Department of Pediatrics, AOU Policlinico Gaetano Martino, 98124 Messina, Italy
Michele Miraglia Del Giudice
Department of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
Elio Novembre
Department of Health Sciences, University of Florence, 50139 Florence, Italy
Angioedema (AE) is a vascular reaction of subcutaneous and submucosal tissues that identifies various clinical pictures and often is associated with wheals. AE without wheals (AEwW) is infrequent. The ability to distinguish between AEwW mediated by mast cells and bradykinin-mediated or leukotriene-mediated pathways is often crucial for a correct diagnostic–therapeutic and follow-up approach. AEwW can be hereditary or acquired. Factors typically correlated with hereditary angioedema (HAE) are a recurrence of episodes, familiarity, association with abdominal pain, onset after trauma or invasive procedures, refractoriness to antiallergic therapy, and lack of pruritus. The acquired forms of AE can present a definite cause based on the anamnesis and diagnostic tests. Still, they can also have an undetermined cause (idiopathic AE), distinguished according to the response to antihistamine in histamine-mediated and non-histamine-mediated forms. Usually, in childhood, AE responds to antihistamines. If AEwW is not responsive to commonly used treatments, it is necessary to consider alternative diagnoses, even for pediatric patients. In general, a correct diagnostic classification allows, in most cases, optimal management of the patient with the prescription of appropriate therapy and the planning of an adequate follow-up.